Analyst Graham Doyle works at UBS and is focused on the Healthcare sector with 12 price targets and ratings documented since 2022 spanning on 3 stocks. Analyst's average stock valuation to be materialised ratio is 40% with an average time for price targets to be met of 17.5 days.
Most recent stock forecast was given on FMS, Fresenius Medical Care AG & Co. KGaA at 02-Nov-2022.
Graham Doyle best performing recommendations are on PHG.
The best stock recommendation documented was for PHG at 7/26/2022. The price target of $16.35 was fulfilled within 38 days with a profit of $5.01 (23.46%) receiving and performance score of 6.17.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
32
$3.12 (10.80%)
55
6 months 9 days ago
3/8 (37.5%)
$10.33 (29.42%)
269
Buy
24.5
11 months 2 days ago
1/1 (100%)
$-6.74 (-21.57%)
245
